A new study found that anticontagion policies implemented worldwide prevented hundreds of millions of coronavirus disease 2019 (COVID-19) infections; reports of child abuse have fallen by more than 50% in New York City as a result of the pandemic; Texas reopens its economy and sees a spike in infections.
Anticontagion policies across China, South Korea, Italy, Iran, France, and the United States effectively prevented or delayed hundreds of millions of additional infections, according to a new study published in Nature. Researchers collected data from 1717 local, regional, and national nonpharmaceutical interventions deployed in the ongoing coronavirus disease 2019 (COVID-19) pandemic. Had the United States not adopted the social distancing measures it did, the country would have experienced roughly 60 million additional infections. That figure rises to 285 million in China. Without any policy interventions, investigators estimate early exponential infection rates of COVID-19 could have reached 38% per day.
Reports of child abuse in New York City dropped by 51% as a result of the COVID-19 pandemic, The New York Times reports. This steep drop-off has authorities worried, as children may be confined to troubled homes with perpetrators or in foster care facilities. Usually, teachers report child abuse to authorities, but as schools shut down and shifted to online class, it became more challenging to detect signs of mistreatment. An average of 1374 cases of child abuse or neglect were reported in the first 8 weeks of spring 2019, but during the same period in 2020, that average fell to 672.
As Texas begins its economic reopening, the state faces record-breaking hospitalizations of individuals with COVID-19, NPR reports. According to the Texas Department of State Health Services, on May 5 there were 1888 patients admitted for COVID-19. On June 8, 1935 individuals were admitted. Despite the uptick, Governor Greg Abbott plans to continue reopening bars, restaurants, and other businesses at 50% capacity. Spikes in cases are not confined to the United States, as on June 8 the World Health Organization reported the highest daily jump in cases at 136,000.
DLBCL Outcomes Vary Sharply for Patients 80 Years and Older
April 16th 2025A majority of cases of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma globally, are diagnosed in patients 65 years and older; these patients are a heterogeneous group, and few studies have investigated how their outcomes are influenced by patient characteristics and care management regimens.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Complete Responses Seen With Emerging Therapies for Chronic Spontaneous Urticaria
April 16th 2025There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and barzolvolimab showing complete response in patients, particularly among those who are difficult to treat.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More